China Regenerative Medicine International Limited Stock
Equities
8158
KYG2129W1380
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 HKD | +9.09% | +11.11% | -67.27% |
Sales 2021 | 283M 36.24M | Sales 2022 | 232M 29.67M | Capitalization | 317M 40.58M |
---|---|---|---|---|---|
Net income 2021 | 13M 1.67M | Net income 2022 | 4M 512K | EV / Sales 2021 | 2.92 x |
Net Debt 2021 | 25.9M 3.32M | Net Debt 2022 | 70.16M 8.99M | EV / Sales 2022 | 1.67 x |
P/E ratio 2021 |
59.9
x | P/E ratio 2022 |
69.6
x | Employees | 46 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 41.97% |
1 day | +9.09% | ||
1 week | +11.11% | ||
Current month | -29.41% | ||
1 month | -35.71% | ||
3 months | -55.56% | ||
6 months | -62.50% | ||
Current year | -67.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chuang Wang
CEO | Chief Executive Officer | 45 | 19-10-17 |
Po Tin Wong
DFI | Director of Finance/CFO | 47 | 22-08-31 |
Jinnan Zhang
CTO | Chief Tech/Sci/R&D Officer | 39 | 18-09-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Man Fai Leung
BRD | Director/Board Member | 66 | 21-12-29 |
Ho Yin Tsang
BRD | Director/Board Member | 38 | 20-01-29 |
Chuang Wang
CEO | Chief Executive Officer | 45 | 19-10-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 0.18 | +9.09% | 396 075 |
24-05-21 | 0.165 | +0.61% | 0 |
24-05-20 | 0.164 | +1.23% | 20,000 |
24-05-17 | 0.162 | 0.00% | 23,425 |
24-05-16 | 0.162 | +10.20% | 85,000 |
Delayed Quote Hong Kong S.E., May 22, 2024 at 04:08 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-67.27% | 6.43M | |
-6.46% | 179B | |
+3.39% | 113B | |
-3.68% | 67.88B | |
+5.44% | 52.03B | |
+5.70% | 43.3B | |
+4.03% | 41.79B | |
+25.42% | 32.49B | |
+14.00% | 25.65B | |
-4.29% | 24.55B |
- Stock Market
- Equities
- 8158 Stock